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Abstract
Background: Strong oestrous symptoms in the mare can cause problems with racing, training and
handling. Since long-acting progesterone treatment is not permitted in mares at competition (e.g.
according to FEI rules), there is a need for methods to suppress unwanted cyclicity. Spontaneous
dioestrous ovulations in the late luteal phase may cause a prolongation of the luteal phase in mares.
Methods: In this preliminary study, in an attempt to induce ovulation during the luteal phase,
human chorionic gonadotropin (hCG) (3000 IU) was injected intramuscularly in four mares
(experimental group) in the luteal phase when a dioestrous follicle ≥ 30 mm was detected. A fifth
mare included in this group was not treated due to no detectable dioestrous follicles ≥ 30 mm.
Four control mares were similarly injected with saline. The mares were followed with ultrasound
for 72 hours post injection or until ovulation. Blood samples for progesterone analysis were
obtained twice weekly for one month and thereafter once weekly for another two to four months.
Results: Three of the hCG-treated mares ovulated within 72 hours after treatment and developed
prolonged luteal phases of 58, 68 and 82 days respectively. One treated mare never ovulated after
the hCG injection and progesterone levels fell below 3 nmol/l nine days post treatment.
Progesterone levels in the control mares were below 3 nmol/l within nine days after saline
injection, except for one mare, which developed a spontaneously prolonged luteal phase of 72 days.
Conclusion: HCG treatment may be a method to induce prolonged luteal phases in the mare
provided there is a dioestrous follicle ≥ 30 mm that ovulates post-treatment. However, the method
needs to be tested on a larger number of mares to be able to draw conclusions regarding its
effectiveness.
Background
According to many mare owners, strong oestrous symp-
toms result in difficulties with training and handling of
the animal [1,2]. One method used earlier was to treat
such mares with long-acting progesterone [3,4]. However,
this treatment is not permitted for use in racing or compe-
tition mares according to many European racing authori-
ties, such as the British Jockey Club [5] and the Swedish
Trotting Association (STC) [6], and also according to the
rules of the International Federation for Equestrian Sports
(FEI) [7]. In addition, in Sweden, short-acting progester-
one treatment, such as altrenogest orally, is prohibited for
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use at competition in riding horses [8] and has a recom-
mended drug withdrawal time of 14 days in Standardbred
racehorses (personal communication, Peter Kallings).
Another method, the crushing of embryos to achieve a
prolonged progesterone phase, has recently been pre-
sented [9]; also, the insertion of glass or plastic balls into
the uterus has been used to prolong the luteal phase in
mares [10,11]. However, some consider these methods to
be improper and the use of intrauterine balls is not per-
mitted in Sweden in racing horses [6]. Therefore there is a
need for alternative techniques. Mares, in contrast to
females of other mammal species, have the ability to ovu-
late during dioestrus, when serum concentrations of pro-
gesterone are high. The frequency of dioestrous
ovulations varies according to breed; in Thoroughbreds
and Quarter Horses as many as 20 % of ovulations occur
during the luteal phase [12], whereas the frequency of
dioestrous ovulations is very low in ponies [13]. The folli-
cles that grow and ovulate during dioestrus do not cause
oestrous signs, due to the suppressive effects of progester-
one on oestrous behaviour [12]. Spontaneous dioestrous
ovulations that occur between one to four days prior to
luteolysis may cause a prolonged luteal phase, due to the
immature corpus luteum being refractory to prostagland-
ins, as shown by exogenous prostaglandin treatment [14].
A refractory state to endogenous prostaglandin for up to
four days after ovulation was also demonstrated by the
use of intrauterine saline infusion [15,16]. The normal
mean dioestrous length, derived from several different
reports, is 14.9 days (range 12.1 to 16.3 days) [17] and in
one study, prolonged luteal phases lasted for a mean of 63
days (range 35–96 days) [18]. Daels et al. [19] demon-
strated that ovulation induced by human chorionic gona-
dotropin (hCG) during altrenogest treatment could lead
to a prolonged luteal phase (5/6 of the mares that ovu-
lated). The present study was designed to evaluate if hCG-
induced ovulation during the late luteal phase in mares
will cause a prolonged luteal phase. Both the method of
Daels et al. [19] and the method used in the present study
would eliminate oestrous behaviour for a period of time
due to high endogenous progesterone levels. However, an
advantage with the method presented in this paper, as
compared to the method of Daels et al. [19], is that exog-
enous altrenogest treatment is not used.
Methods
Animals, management and housing
The experiment was performed in April-September 2004.
All procedures were approved by the Ethical Committee
for Experimentation with Animals, Sweden. Nine mares
weighing between 450 and 550 kg and with an age span
of four to 20 years were used in the study. Eight of the
mares were Standardbred trotters and one was a Swedish
warmblood mare (mare A). The mares were kept at the
Division of Comparative Reproduction, Obstetrics and
Udder Health, Department of Clinical Sciences and were
all owned by the department. From the first week of
December 2003, the mares were put on light treatment for
16 hours per day. Prior to the experimental period, the
mares had been teased daily with a stallion, which
showed that all mares had normal oestrous cycle lengths
for at least two cycles before commencing the study (three
cycles in all mares but one). In April and May, all mares
were stabled indoors on straw in individual loose boxes
during the night and let out at pasture during the day
(approximately 08.00 to 15.00 h). The mares were fed
grass hay (morning, noon and evening) and a small
amount of oats, soaked sugar beet and a mineral supple-
ment (afternoon). From the first week of June and after at
least one month of experimental study at the department,
seven of the mares were transported to pasture 30 km
away from the department, where they were kept out-
doors 24 hours per day until the end of the study. The
mares always had free access to water. One mare (mare T)
was moved to pasture after only 15 days of study; she had
received hCG, but did not ovulate and showed symptoms
of oestrus at the department before being moved.
Experimental procedure
The mares were randomly divided into an experimental
group (n = 5) and a control group (n = 4). When the mares
were at the department, teasing with a stallion was per-
formed daily and oestrous signs were scored as follows: +
1 for tail raise, + 1 for clitorial winking/urination and + 1
for standing in a straddled posture, with behavioural
oestrus defined as a score of + 2 or above. When behav-
ioural oestrus was detected, transrectal ultrasound exami-
nation (six MHz linear probe, 485 Anser, Pie Medical,
Maastricht, Netherlands) of the uterus and ovaries was
performed every other day until ovulation was confirmed.
Thereafter, from approximately day eight after ovulation
in dioestrus, transrectal ultrasound examination was
again performed every other day to determine the size of
the dioestrous follicles. Three mares (mares Ev, Ma and L)
were for technical reasons not examined at oestrus and
only followed from day eight after the last oestrous signs
were detected; they had a corpus luteum and high proges-
terone levels at treatment. When a follicle ≥ 30 mm of
diameter was detected, 3000 IU of hCG (Pregnyl®, Orga-
non AB, Gothenburg, Sweden) or an equal volume of
saline (2 ml) was injected intramuscularly. The mares
were then followed with ultrasound for up to 72 hours or
until ovulation. Thereafter the mares were examined with
ultrasound once weekly for three weeks. One mare (mare
T) was only examined twice after treatment; she had not
ovulated after the hCG injection and showed oestrous
signs during teasing eight days after treatment. Starting on
the treatment day (hCG or saline), samples for progester-
one analysis were obtained from the jugular vein into a
heparinised evacuated tube. Thereafter, blood samples forActa Veterinaria Scandinavica 2006, 48:12 http://www.actavetscand.com/content/48/1/12
Page 3 of 6
(page number not for citation purposes)
progesterone analysis were taken twice weekly for at least
one month and then once weekly for another two to four
months. One mare (mare A) was only sampled once a
week for the whole duration of the study. This mare, how-
ever, was teased daily and examined with ultrasound once
or twice per week throughout the study period. In two
mares (mares Ex and A) two and one of the samples,
respectively, were taken eight or nine days apart (see Fig.
1). All blood samples were immediately centrifuged and
the plasma stored at -20°C. Mares were defined as being
in luteal phase if progesterone values were above 3 nmol/
l [17] in samples taken twice weekly and above 10 nmol/
l in samples taken once weekly [20,21]. If no follicles with
a size of at least 30 mm were detected in one dioestrous
period, the mares were followed as above for, at most, a
total of three luteal phases.
Hormone analysis
The concentration of progesterone in peripheral blood
plasma was determined using a solid-phase radioimmu-
noassay (Coat-a-Count Progesterone, Diagnostic Products
Corporation, Los Angeles, USA). The kit was used accord-
ing to the manufacturer's instructions. The relative cross-
reactions of the antibody were 0.9 % with corticosterone
and 0.1 % with testosterone. The intra-assay coefficients
of variation for progesterone were as follows: 1.4 % at 3.4
nmol/l; 5.2 % at 24.2 nmol/l; 4.1 % at 56.1 nmol/l. The
minimal assay sensitivity of progesterone was 0.1 nmol/l.
Results
The main results are summarised in Table 1. Three of nine
mares developed follicles that were above 30 mm (and
thus could be treated) in the first luteal phase examined.
The remaining mares developed large enough follicles in
the second (n = 4), third (n = 1) or in none (n = 1) of the
luteal phases studied. Depending on if a mare was treated
in the first, second or third dioestrous period after the start
of the experiment (due to follicle size), mares were fol-
lowed for between 90 to 160 days after treatment. Three
of the four hCG-treated mares ovulated, resulting in luteal
phases, as defined in materials and methods, lasting for
58, 68 and 82 days post-treatment respectively (Table 1).
Figure 1 shows their post-treatment progesterone concen-
trations. These mares were treated between eight and ten
days after ovulation was confirmed by ultrasound (every
other day) or after last detected oestrous signs (mare Ev),
which means their actual luteal phases lasted for at least
69, 77 and 90 days. Two of the hCG-treated mares (mares
A and Ev) were never moved to pasture and were therefore
teased daily for symptoms of oestrus and mare A exam-
ined with ultrasound. The mares showed oestrous signs at
days 62 (mare Ev) and 88 (mare A) post treatment and
their progesterone levels were then below 3 nmol/l. Mare
A had two additional luteal phase ovulations which were
associated with two peaks in her progesterone levels (see
Fig. 1). The third mare (mare Ex) did not show any symp-
toms of oestrus during the time she was still kept at the
department (37 days). One additional mare in the exper-
imental group (mare O) never developed a dioestrous fol-
licle above 30 mm in any of the three luteal phases
studied and was thus never treated. Another mare in this
group (mare T) injected with hCG in the third luteal phase
studied did not ovulate as a result, although she had a fol-
licle above 30 mm at treatment. This mare showed symp-
toms of oestrus eight days after the injection had been
given. The progesterone level was then low (< 3 nmol/l).
None of the control mares treated with saline ovulated
during the luteal phase. In three mares (mares Ma, L and
J), progesterone values dropped below 3 nmol/l within
nine days post-injection. Two of these mares (mares Ma
and L) showed oestrous symptoms in association with the
drop in progesterone resulting in dioestrous lengths of 18
and 23 days respectively. Mare J had silent oestrus and
ultrasound examination three days after the low proges-
terone values revealed a new corpus luteum (soft on pal-
pation) and progesterone levels increased to 28 nmol/l
four days later. Mare Me never developed a follicle ≥ 30
mm in the first luteal phase studied and got a spontane-
ous prolongation of this luteal phase. Therefore, she was
induced with prostaglandin F2α (on day 22 of dioestrus)
(1 ml Dinolytic® vet., 5 mg, Orion, Animal Health, Sollen-
tuna, Sweden). She also developed a spontaneously pro-
longed luteal phase after the saline treatment that lasted
Progesterone levels in hCG treated mares that ovulated after  treatment Figure 1
Progesterone levels in hCG treated mares that ovu-
lated after treatment. 'a' and 'b' = peaks associated with 
formation of corpora lutea. * = samples taken 8 or 9 days 
apart. Dashed lines show the cut-off levels for progesterone 
samples taken twice weekly (3 nmol/l) or once weekly (10 
nmol/l)
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for 72 days. Figure 2 shows mare Me's progesterone levels
during the study and also the progesterone levels of mare
J for comparison with a mare that cycled normally. Mare
Me showed no symptoms of oestrus after saline treatment
during the time she was kept at the department (28 days).
Progesterone analysis of all of the samples showed that
one of the control mares (mare Ma) that came into oestrus
after the saline injection thereafter developed a prolonged
luteal phase lasting for 76 days.
Discussion
In the present study, the fact that immature corpora lutea
do not respond to the luteolytic effect of endogenous
prostaglandin was utilised in an attempt to produce a pro-
longed luteal phase [15,16,22]. The mares in the hCG
treatment group that developed prolonged luteal phases
ovulated between days ten and 13 in dioestrus. Thus, the
corpora lutea were a maximum of four days old, and pre-
sumably refractory, at the time of endogenous prostaglan-
din release which occurs around days 14 to 17 of dioestrus
[22,23]. Failure of the endometrium to release prostaglan-
din at the time of luteolysis (for example due to chronic
endometritis, maternal recognition of pregnancy or for
idiopathic reasons) can also cause a prolonged luteal
phase in the mare [23-27]. It would have been of interest
to measure prostaglandin metabolite levels to rule out
that impaired prostaglandin release was not a cause of the
prolonged luteal phases. Unfortunately, this was for prac-
tical reasons not possible in the present study. Although
all of the mares had shown normal cycle lengths prior to
the study, one mare (mare Me) developed a prolonged
luteal phase in the first cycle studied and also, in the sub-
sequent, saline treated, cycle.
The mares that ovulated as a result of the hCG treatment
developed prolonged luteal phases that lasted for approx-
imately two to three months. Other studies have also
shown prolonged luteal activity in the mare to last for
similar lengths of time [28,29]. It has been proposed that
in order for the uterus to produce and release prostaglan-
din in response to oxytocin (as occurs at luteolysis), a
period of low progesterone levels (i.e. oestrus) followed
by a period with elevated progesterone concentrations
(i.e. dioestrus), is required [27,30,31]. An initial prolon-
gation of the luteal phase, where a drop in progesterone
levels does not occur at the expected time, seems to render
the uterus less sensitive to oxytocin [27]. This in turn
results in impaired prostaglandin synthesis and release
and a prolonged luteal phase lasting for up to three
months. For unknown reasons, the uterus eventually
regains its responsiveness and oxytocin induced prostag-
Progesterone levels after saline treatment in two control  mares Figure 2
Progesterone levels after saline treatment in two 
control mares. Mare Me developed a spontaneously pro-
longed luteal phase. Dashed lines show the cut-off levels for 
progesterone samples taken twice weekly (3 nmol/l) or once 
weekly (10 nmol/l)
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Table 1: Summary of results of saline- and hCG-treated mares
Treatment Mare Cycle no. treated Day after confirmed ovulation Length of luteal phase after 
treatment
treatment was 
given
new ovulation was 
detected
hCG (3000 IU) Mare A two 8 10 82 days
Mare Ev one 10* 13 58 days
Mare Ex one 10 13 68 days
Mare T three 10 ----- 9 days
Saline Mare Ma one 10* ----- 8 days
Mare Me two 7 ----- 72 days
Mare J two 7 ----- 8 days
Mare L two 9* ----- 9 days
* Day after last oestrous signsActa Veterinaria Scandinavica 2006, 48:12 http://www.actavetscand.com/content/48/1/12
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landin production is again possible, finally resulting in
luteolysis and oestrus [27,29].
It has been suggested that prolonged luteal activity may be
caused by more than one corpora lutea developing in suc-
cession rather than by the persistence of a single corpus
luteum [32]. In the present study, the luteal phase length
was determined by progesterone analysis alone, and
therefore it is not known if the corpora lutea developed as
a result of the hCG treatment was active throughout the
whole prolonged luteal phase or whether subsequent cor-
pora lutea developed. One mare (mare A), however, was
examined with ultrasound throughout the study. In that
mare, two peaks in the progesterone curve were found to
be associated with two ovulations during the luteal phase
(in addition to the hCG induced ovulation), which might
have contributed to the increased progesterone levels (see
Fig. 1).
Of the mares that ovulated as a result of the hCG injec-
tion, 100 % (3/3) developed prolonged luteal phases, i.e.
75 % of the total number of hCG- treated mares. Among
the control mares, 25 % (1/4) developed a spontaneously
prolonged luteal phase in the saline treated cycle (this
mare showed prolonged luteal activity twice during the
study; see results). In the oestrous cycle following the
saline treated cycle, another mare developed a spontane-
ously prolonged luteal phase. Thus, in total, 2/4 control
mares showed prolonged luteal activity. The incidence of
so-called spontaneous prolongation of luteal activity in
the mare has been reported to be common in some
breeds. One study following seven mares (Thoroughbreds
and Quarter Horses) over a two-year period reported 12
cases of prolonged luteal phase [29]. Another study has
reported an incidence of prolonged luteal phase of only
3.6 % in trotter mares [33].
According to Fortune [34], only about one third of mares
have a secondary follicular wave. Other studies, however,
show that the majority of mares do have a secondary fol-
licular wave that occurs during dioestrus, which is accom-
panied by a rise in FSH and can lead to ovulation [18,35].
Breed differences may explain these divergent findings.
Studies have demonstrated that Thoroughbreds have a
higher incidence of two major waves compared to Stand-
ardbreds, Quarter horses and ponies [17,36]. The present
study indicates that maximum follicular size during dioe-
strus may vary within the same animal and that some
mares may never develop large follicles (> 30 mm) in the
luteal phase. Perhaps using Thoroughbreds as opposed to
Standardbreds would have shown different results.
One hCG treated mare with a dioestrous follicle above 30
mm did not ovulate as a result of the treatment. Few stud-
ies have been performed on what the optimal follicle size
is when inducing ovulation with hCG, although most
studies use 35 mm as minimal size when mares are in
oestrus, which is also followed in practice [27,37,38]. That
the follicle is actively growing, and not in regression, is
probably crucial [17]. The reason for selecting a follicle
size of 30 mm or above was because it was suspected that
few mares would develop very large follicles in dioestrus,
which also was confirmed. The follicle of one mare did
not ovulate after hCG-treatment, maybe because of the
immaturity of the follicle. It has been shown that only fol-
licles with nine to ten granulosa cell layers respond to FSH
and continue their growth and that only a few of these fol-
licles are able to ovulate [34]. Oestrogen and androgen
production by the follicle seems to be important in its
final maturation and it has been demonstrated that folli-
cles developing during the luteal phase produce less oes-
trogens, which may result in dioestrous follicles being less
responsive to hCG [34].
Thus, there are limitations to the usefulness of the present
method in practice. Mares may have to be followed for
more than one luteal phase before a follicle of suitable
size is detected and some mares may never develop large
enough follicles. Also, even if the follicle is larger than 30
mm, it is not certain that ovulation will occur. However,
modifying the method by using repeated injections of
hCG in smaller doses may give better results. Ovulation of
follicles as small as 20 mm has been achieved using 200
IU of hCG given daily (seven out of eight pony mares ovu-
lated in a mean of nine days) [39].
Conclusion
As a method of inducing prolonged luteal phase in the
mare, the results of this preliminary study may suggest the
use of hCG in the late luteal phase, providing a follicle
greater than 30 mm is present and ovulates as a result of
the treatment. The method does not involve the use of
substances banned for competition purposes and could
thus potentially be used for competition mares whose per-
formance is affected by the oestrous cycle. However, to
conclude that the method is effective and applicable to
practice, it is necessary to repeat the study using a larger
number of mares.
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